ARCHIVES

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

This article is from The Cancer Letter archive.

Vol. 04 No. 11 | March 17, 1978

Download PDF Visit The Full Archive

Related Articles

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002